Green Thumb Industries (GTBIF) Return on Capital Employed (2020 - 2026)
Green Thumb Industries (GTBIF) posted Return on Capital Employed of 5.2% for Q1 2026, down 4.26% on a QoQ basis from 5.43% in Q4 2025, and down 310.0% year-over-year from 2.47% in Q1 2025.
Green Thumb Industries (GTBIF) Return on Capital Employed (2020 - 2026) Analysis & Trends
Green Thumb Industries' Return on Capital Employed history runs 7 years deep, the most recent figure standing at 5.2% for Q1 2026.
- Quarterly Return on Capital Employed fell 310.0% year-over-year to 5.2% in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 5.2% (down 310.0% YoY) and the FY2025 annual result came in at 5.54%, down 402.0% from the prior year.
- Return on Capital Employed was 5.2% for Q1 2026 at Green Thumb Industries, down from 5.43% in the prior quarter.
- Across five years, Return on Capital Employed topped out at 10.29% in Q2 2024 and bottomed at 3.81% in Q3 2023.
- A 5-year average of 7.47% and a median of 7.8% in 2023 frame the typical range for Return on Capital Employed.
- Annual changes were most pronounced in 2023 — Return on Capital Employed sank 619 bps — and 2024, when it soared 645 bps.
- Green Thumb Industries' Return on Capital Employed stood at 5.27% in 2022, then jumped by 48 bps to 7.8% in 2023, then gained by 22 bps to 9.51% in 2024, then sank by 43 bps to 5.43% in 2025, then slipped by 4 bps to 5.2% in 2026.
- Business Quant data shows GTBIF's Return on Capital Employed at 5.2% in Q1 2026, 5.43% in Q4 2025, and 7.47% in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROCE (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | 8.52% |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | 27.36% |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | -1.50% |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | 21.43% |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | 0.46% |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | 20.04% |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | 5.24% |
| 10 | Green Thumb Industries | 1.63 Bn | 1.29 Bn | 143.65 Mn | 5.20% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 5.20% |
| Dec 31, 2025 | 5.43% |
| Sep 30, 2025 | 7.47% |
| Jun 30, 2025 | 7.63% |
| Mar 31, 2025 | 8.29% |
| Dec 31, 2024 | 9.51% |
| Sep 30, 2024 | 9.20% |
| Jun 30, 2024 | 10.29% |
| Mar 31, 2024 | 8.99% |
| Dec 31, 2023 | 7.80% |
| Sep 30, 2023 | 3.81% |
| Jun 30, 2023 | 3.85% |
| Mar 31, 2023 | 4.86% |
| Dec 31, 2022 | 5.27% |
| Sep 30, 2022 | 9.49% |
| Jun 30, 2022 | 10.03% |
| Mar 31, 2022 | 9.85% |
| Dec 31, 2021 | 10.41% |
| Sep 30, 2021 | 11.50% |
| Jun 30, 2021 | 11.94% |